{"id":"W2127783189","doi":"10.1158/1078-0432.ccr-08-2076","title":"A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Mucositis; Tolerability; Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacodynamics; Pharmacology; Internal medicine; Phases of clinical research; Gastroenterology; Adverse effect; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749477,0.0001529427,0.0003589288,0.00006748865,0.0000819213,0.00002534509,0.0003662863,0.0001528072,0.00003013038],"category_scores_gemma":[0.0008206196,0.0001024865,0.00006537561,0.0003727794,0.0003867671,0.000008011766,0.0001837132,0.0003331728,0.000001477365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000608143,"about_ca_system_score_gemma":0.0003575731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006842428,"about_ca_topic_score_gemma":0.0002893619,"domain_scores_codex":[0.9975564,0.0003748133,0.0006439736,0.000540156,0.0004468379,0.0004377844],"domain_scores_gemma":[0.9984958,0.0002152857,0.0001034356,0.0005415022,0.000477293,0.000166656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4487703,0.003558399,0.07818329,0.00006799179,0.00009203435,0.00001291084,0.0002338716,0.0004724382,0.0431755,0.00002695435,0.0009350702,0.4244713],"study_design_scores_gemma":[0.3539324,0.1339045,0.4095578,0.0006502463,0.00006858962,0.000004233463,0.0001595656,0.0002415202,0.07571976,0.001105898,0.02355918,0.001096217],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969198,0.0005862707,0.00003216797,0.0008913417,0.0001270438,0.001263023,0.00005643086,0.000005656116,0.000118238],"genre_scores_gemma":[0.9987601,0.0002119931,0.0001714682,0.0004397405,0.0001966251,0.0001300107,0.0000194334,0.00001662015,0.00005401436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.423375,"threshold_uncertainty_score":0.4179279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08724902439158091,"score_gpt":0.4557811363761681,"score_spread":0.3685321119845872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}